logo

Tiziana Life Sciences Plc (TLSA)



Trade TLSA now with
  Date
  Headline
1/13/2021 2:34:13 AM Tiziana Life Sciences Appoints Neil Graham Chief Medical Officer
8/24/2020 3:07:05 AM Tiziana Granted Patent On Methods And Use Of Anti-IL-6/IL-6 Receptor Monoclonal Antibodies
6/29/2020 3:13:55 AM Tiziana Life Sciences Executes Agreement With STC Biologics For GMP Manufacturing Of TZLS-501
5/29/2020 2:13:54 AM Tiziana Life Sciences Says StemPrintER Outperforms Oncotype DX In Analysis With 800+ Samples
5/22/2020 2:26:05 AM Tiziana Lifesciences Intends To Demerge StemPrintER Genomics-Based Personalized Medicine Business As Separate Listed Co.
4/27/2020 9:37:11 AM Tiziana Files Patent Application On Combination Of NP-ACT D With Anti-IL-6R
4/9/2020 6:52:25 AM Stock Alert: Tiziana Life Sciences Up 96% In Pre-market
3/11/2020 7:36:18 AM Tiziana Life Sciences Developing TZLS-501 As A Potential Treatment For Coronavirus Patients
1/21/2020 12:44:54 PM Tiziana Life Sciences Appoints Gregor MacRae As Non-executive Director
9/16/2019 7:48:19 AM Tiziana Life Sciences Announces FDA Approval To Initiate Phase I Clinical Trial With Foralumab In Healthy Volunteers